CLLS CIK: 1627281

Cellectis S.A.

  • France
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY23
FY23
FY24
FY25
FY23 – FY25

Assets

(positive)
millions USD
FY23:
–
FY23:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
millions USD
FY23:
–
FY23:
–
FY23:
–
FY24:
–
FY25:
–
Total assets
Change from FY23 to FY25
millions USD
FY23:
228
FY23:
210
FY23:
334
FY24:
384
FY25:
325

Liabilities & Equity

(negative)
Change from FY23 to FY25
millions USD
FY23:
42.0
FY23:
44.0
FY23:
155
FY24:
166
FY25:
146
(negative)
Change from FY23 to FY25
millions USD
FY23:
–
FY23:
–
FY23:
94.4
FY24:
86.2
FY25:
103
(positive)
Change from FY23 to FY25
millions USD
FY23:
96.6
FY23:
76.1
FY23:
84.7
FY24:
131
FY25:
75.9
Total liabilities & equity
Change from FY23 to FY25
millions USD
FY23:
–
FY23:
–
FY23:
334
FY24:
384
FY25:
325

All amounts in millions USD Data source:SEC EDGAR